External site

By following this link, you are leaving Medically and entering a website that is not owned or controlled by Roche. Roche does not take any responsibility for access to or use of this website, nor for any content therein.

Leave site
Home Respiratory ERS 2023
Roche and Genentech at

ERS 2023

September 09 - September 13
Milan, Italy / Virtual (Hybrid)
ersnet.org
Add to calendar
Share feedback
Share page
-
Medical Materials
Highlights
Coming soon

Sign up or login to unlock the full suite of MEDICALLY features
Independent content
Sep 25 / Springer Healthcare
European Respiratory Society (ERS) 2023: In-depth report
This in-depth report provides an overview of the latest advances in the diagnosis, treatment and management of chronic obstructive pulmonary disease and interstitial lung disease presented at ERS 2023.
Respiratory Chronic Obstructive Pulmonary Disease Idiopathic Pulmonary Fibrosis Interstitial Lung Disease Respiratory Disease ERS-2023
Bookmark this
Share page

Sign up or login to unlock the full suite of MEDICALLY features
Aug 28 / Roche and Genentech
Autoantibody Positivity in Idiopathic Pulmonary Fibrosis: Outcomes From the Pulmonary Fibrosis Foundation Patient Registry
This poster describes the baseline characteristics and clinical outcomes in patients with IPF from the Pulmonary Fibrosis Foundation Patient Registry (PFF-PR), stratified by baseline AAb status.
Respiratory Idiopathic Pulmonary Fibrosis ERS-2023

Sign up or login to unlock the full suite of MEDICALLY features
Aug 27 / Roche and Genentech
ALIENTO and ARNASA: Study Designs of Two Randomised, Double-Blind, Placebo-Controlled Trials of Astegolimab in Patients With COPD
This poster reports the designs of the Phase IIb ALIENTO (NCT05037929) and Phase III ARNASA (NCT05595642) pivotal studies investigating the efficacy and safety of astegolimab in patients with COPD.
Respiratory Chronic Obstructive Pulmonary Disease ERS-2023

You have successfully signed up for this alert. You will be notified when it is available.

Sign up or login to unlock the full suite of MEDICALLY features

Sign up or login to unlock the full suite of MEDICALLY features
ERS 2023 In-depth Report
September 25
Springer Healthcare
Open asset

You have successfully signed up for this alert. You will be notified when it is available.

Sign up or login to unlock the full suite of MEDICALLY features

Sign up or login to unlock the full suite of MEDICALLY features
ERS 2023 In-depth Report
September 25
Springer Healthcare
Open asset

This website is intended for healthcare professionals outside the United Kingdom (UK) and Australia. Registration status and prescribing information of medicinal products may differ between countries. Please refer to local product information for any medicinal products mentioned on this website.